Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million